Selection of Treatment Regimens for Recurrent Cervical Cancer

Selection of Treatment Regimens for Recurrent Cervical Cancer

ObjectiveThe selection of individualized treatment for recurrent cervical cancer is challenging. This study aimed to investigate the impact of various therapies on survival outcomes after recurrence.MethodsEligible patients were diagnosed with recurrent cervical cancer between March 2012 and April 2...

Full description

Bibliographic Details
Main Authors:	Xiaopei Chao, Xiaochen Song, Huanwen Wu, Yan You, Ming Wu, Lei Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Oncology
Subjects:	cervical cancer recurrence radiotherapy chemotherapy surgery progression-free survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.618485/full

Similar Items

The Clinical Aspects and Prognostic Factors Concerning Survival in Patients With Recurrent Cervical Cancer After Radical Hysterectomy and Adjuvant Chemoradiotherapy
by: Hui-Ting Zhu, et al.
Published: (2022-01-01)

Diagnostic Strategies for Recurrent Cervical Cancer: A Cohort Study
by: Xiaopei Chao, et al.
Published: (2020-12-01)

Minimally invasive versus open radical trachelectomy for early-stage cervical cancer: protocol for a multicenter randomized controlled trial in China
by: Xiaopei Chao, et al.
Published: (2020-12-01)

Cisplatin-based chemotherapy with or without bevacizumab for Chinese postmenopausal women with advanced cervical cancer: a retrospective observational study
by: Xiaoli He, et al.
Published: (2020-05-01)

Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy
by: Gui-Fen Ma, et al.
Published: (2024-01-01)

Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer
by: Yu XL, et al.
Published: (2021-12-01)

FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: comparison with MRI
by: Stojiljkovic Milica, et al.
Published: (2022-11-01)

Long term follow up of recurrent uterine cervical cancer: A Case Report
by: Fatemeh Homaee Shandiz, et al.
Published: (2014-07-01)

Selective use of concurrent chemotherapy in elderly cervical cancer patients treated with definitive radiotherapy: experience from two institutions
by: You K, et al.
Published: (2019-05-01)

Surveillance Epidemiology and End Results (SEER) Analysis Demonstrates Improvement in Overall Survival for Cervical Cancer Patients Treated in the Era of Concurrent Chemoradiotherapy
by: Howard C. Hsu, et al.
Published: (2015-04-01)

Efficacy of 93 Cases of Recurrent Ovarian Cancer
by: WANG Juan, et al.
Published: (2020-01-01)

Management of Recurrent Meningiomas: State of the Art and Perspectives
by: Marco Vincenzo Corniola, et al.
Published: (2022-08-01)

Chemotherapy for advanced or recurrent cervical cancer
by: Toshiharu Kamura, et al.
Published: (2013-06-01)

Results of pelvic exenteration in patients with cervical cancer: clinical experience
by: Golib A. Khakimov, et al.
Published: (2023-12-01)

Survival analysis of postoperative recurrence of meningioma: 176 cases report
by: HUANG Guan⁃you, et al.
Published: (2022-11-01)

Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study
by: Yaobin Lin, et al.
Published: (2022-05-01)

Chemotherapy alone versus chemotherapy plus 125I brachytherapy for the second-line treatment of locally recurrent cervical cancer after/with radical treatment: A propensity score analysis
by: Zhimei Huang, et al.
Published: (2024-01-01)

Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell Carcinoma
by: Shinichi Tate, et al.
Published: (2021-06-01)

Efficacy and safety of FLOT regimen vs DCF, FOLFOX, and ECF regimens as perioperative chemotherapy treatments for resectable gastric cancer patients; a report from the middle east
by: Pegah Farrokhi, et al.
Published: (2022-01-01)

Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits
by: Abigail S. Zamorano, et al.
Published: (2017-11-01)

Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trials
by: Xiaojie Wang, et al.
Published: (2017-03-01)

The impacts of minimally invasive surgery on intermediate- or high-risk cervical cancer patients received adjuvant radiotherapy
by: Qiying Zhang, et al.
Published: (2022-11-01)

Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis
by: Xia Wang, et al.
Published: (2023-10-01)

Radiotherapy for Vaginal Recurrences of Cervical Cancer in Patients After Prior Surgery: Analysis of Effect and Prognostic Factors
by: Junfang Yan, et al.
Published: (2021-09-01)

Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade
by: Radek Lakomy, et al.
Published: (2020-07-01)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
by: Congxiao Wang, et al.
Published: (2020-06-01)

Recurrent Endometrial Cancer: Which Is the Best Treatment? Systematic Review of the Literature
by: Stefano Restaino, et al.
Published: (2022-08-01)

Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study
by: Xiaoyue Wu, et al.
Published: (2023-01-01)

A Retrospective Evaluation of the Retrosigmoidal Approach for Petroclival Meningioma Surgery and Prognostic Factors Affecting Clinical Outcome
by: Waseem Masalha, et al.
Published: (2022-04-01)

Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: Retrospective Single-Center Study
by: Liliana Mereu, et al.
Published: (2023-10-01)

Recurrent Esthesioneuroblastoma: Long-Term Outcomes of Salvage Therapy
by: Garrett Ni, et al.
Published: (2023-02-01)

Stromal Neutrophil Extracellular Trap Density Is an Independent Prognostic Factor for Cervical Cancer Recurrence
by: Bin Yan, et al.
Published: (2021-08-01)

Pretreatment total lymphocyte count as a prognostic factor of survival in patients with recurrent cervical cancer after definitive radiation-based therapy: a retrospective study
by: Ekasak Thiangphak, et al.
Published: (2023-09-01)

Comparison of Survival and Postoperative Complication of Stage Ⅰb2-Ⅱa2 Cervical Cancer Patients Among Three Kinds of Therapeutic Regimens
by: JIANG Hongqing, et al.
Published: (2019-09-01)

Is Immune Therapy Plus Chemotherapy More Effective Than Immune Therapy Alone for Unresectable Recurrent Nasopharyngeal Carcinoma?
by: Xin Zhou, et al.
Published: (2021-10-01)

Laparoscopic vs. Abdominal Radical Hysterectomy for Locally Advanced Cervical Cancer
by: Wenhui Wang, et al.
Published: (2019-11-01)

Treatment for Locally Resectable Stage IIIC1 Cervical Cancer: A Retrospective, Single-Institution Study
by: Yoko Kashima, et al.
Published: (2023-02-01)

Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis
by: Paolo Sala, et al.
Published: (2022-02-01)

Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon‐ion radiotherapy
by: Atsushi Musha, et al.
Published: (2023-07-01)

A Machine Learning Tool to Predict the Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer
by: Francesca Arezzo, et al.
Published: (2021-01-01)